Evidence map›Paper›PMID 33986498›Full record

ArticleBone marrow transplantation2021

The paradox of haematopoietic cell transplant in Latin America.

Gregorio Jaimovich, Robert Peter Gale, Ignacio Hanesman, Alberto Vazquez, Nelson Hammerschlak, Belinda Pinto Simoes, Juan Carlos Fagundo, Marcos Hernandez Jimenez, David Gomez-Almaguer, Ernesto Fanilla and 8 more

Abstract read
PubMed Publisher
In one paragraph

Article in Bone marrow transplantation, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors.

Gregorio JaimovichHospital Universitario Fundacion Favaloro, Buenos Aires, Argentina. gregjaim@gmail.com.ORCID http://orcid.org/0000-0003-2555-6673
Robert Peter GaleCentre for Haematology Research, Department of Immunology and Inflammation, Imperial College London, London, UK.
Ignacio HanesmanMacro Consulting, Buenos Aires, Argentina.
Alberto VazquezHospital Maciel, Montevideo, Uruguay.
Nelson HammerschlakHospital Israelita Albert Einstein, São Paulo, Brazil.ORCID http://orcid.org/0000-0002-5140-5310
Belinda Pinto SimoesRibeirao Preto Medical School, Sao Paulo University, Ribairao Preto, Brazil.
Juan Carlos FagundoInstituto de Hematología e Inmunología, Habana, Cuba.
Marcos Hernandez JimenezUniversidad de Carabobo Ciudad Hospitalaria Dr Enrique Tejera, Caracas, Venezuela.ORCID http://orcid.org/0000-0002-3347-7230
David Gomez-AlmaguerHospital Universitario "Dr. José Eleuterio González", Universidad Autónoma de Nuevo León, Monterrey, Mexico.ORCID http://orcid.org/0000-0002-0460-6427
Ernesto FanillaInstituto Oncologico Nacional, Panama, Panama.
Juan NavarroHospital Rebagliati, Lima, Peru.
Bella MaldonadoHospital SOLCA, Guayaquil, Ecuador.ORCID http://orcid.org/0000-0003-2779-2741
Willem BujanHospital Mexico, San Jose, Costa Rica.
Julia Palma BehnkeHospital Calvo Mackenna, Santiago, Chile.
Cristobal FrutosInstituto de Prevision Social, Asuncion, Paraguay.
Amado KardussPrograma de Trasplante de Medula Osea- Clinica Las Americas, Medellin, Colombia.ORCID http://orcid.org/0000-0001-8372-102X
Sebastian GaleanoHospital Británico, Montevideo, Uruguay.
Juliana Martinez RolónFUNDALEU, Buenos Aires, Argentina.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Hematopoietic cells transplants are technically complex and expensive imposing a huge burden on health care systems, especially those in developing countries and regions. In 2017 > 4500 transplants were done in 13 Latin American countries with established transplant programmes. We interrogated data on transplant rate, cost, funding source, hospital type, Gini coefficient and the United Nations Development Programme Inequality-Adjusted Human Development Index to determine co-variates associated with transplant development. Transplant rates varied almost 30-fold between the 13 countries from 345 in Uruguay to 12 in Venezuela with a regional transplant rate 7-8-fold lower compared with the US and EU. We found significant correlations between higher transplant cost, public funding, transplants in private hospitals with transplant rate. Low cost per transplant regardless of payor and transplants done in public hospitals were associated with low transplant rates. In contrast, high cost per transplant funded by the government and transplants done in private hospitals were associated with high transplant rates. Surprisingly, we found transplant rates were higher when transplants cost more, when they were done in private for-profit hospitals and payed for with public funds. These data give insights how to increase transplant rates in Latin America and other developing regions.

Indexed as

Hematopoietic Stem Cell TransplantationTransplantsDelivery of Health CareHumansLatin AmericaUruguay

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.